Rheumatic manifestations of systemic diseases (hemochromatosis, Wilson
Matthew Baker, MD, MS
Stanford University
Menlo Park, CA, United States
Disclosure(s): Beigene: Grant/Research Support (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); Horizon Therapeutics: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); Mobility Bio: Consultant (Ongoing); Nēsos: Advisor or Review Panel Member (Terminated, October 1, 2018), Consultant (Terminated, October 1, 2018); Roivant: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); Sanofi: Grant/Research Support (Ongoing); Zenas Biopharma: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing)
Nisha Gilotra, MD
Johns Hopkins Medicine
Baltimore, MD, United States
Disclosure(s): Kiniksa Pharmaceuticals: Consultant (Ongoing)
Arthur Yee, MD, PhD
Hospital for Special Surgery
New York, NY, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
This session with provide learners with an overview of sarcoidosis in 2023, using cardiac sarcoid as an example of organ-specific disease. It will discuss different modalities used in the diagnosis and monitoring of disease, focusing on the immunologic nature of the disease. Finally, it will review the different treatments available for these patients and how choices may vary depending on the organ involved.
Speaker: Arthur Yee, MD, PhD – Hospital for Special Surgery
Speaker: Nisha Gilotra, MD – Johns Hopkins Medicine
Speaker: Matthew Baker, MD, MS – Stanford University